Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Courtney

Showing results (501-510 of 539) with videos related to

Pageof 54
Sort By:
Gynecologic Oncology|November 6, 2021
Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancerT J Orellana, H Kim, S Beriwal, et al.
Pediatric Diabetes|November 12, 2020
Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trialKate C Verbeeten, Maria Esther Perez Trejo, Ken Tang, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with AdV-IL2 (TG 1021) in unresectable digestive adenocarcinoma. Phase I-II study, first inclusionsF N Gilly, A C Sayag-Beaujard, J Bienvenu, et al.
Chemmedchem|April 23, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oximeRaffaella Amici, Chiara Bigogno, Roberto Boggio, et al.
BJU International|January 12, 2013
Discrediting microscopic pyuria and leucocyte esterase as diagnostic surrogates for infection in patients with lower urinary tract symptoms: results from a clinical and laboratory evaluationAnthony S Kupelian, Harry Horsley, Rajvinder Khasriya, et al.
The Journal of Clinical Investigation|December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsH Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Annals of Internal Medicine|December 1, 1979
Controlled trials of hemoperfusion for intoxicationO S Better, G Brunner, T M Chang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2022
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?S Jaishankar, P M Pifer, R Bhargava, et al.
Diabetologia|October 7, 2011
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a conceptJ Amar, M Serino, C Lange, et al.
Journal of Medicinal Chemistry|December 7, 2010
Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinaseMichael E Prime, Stephen M Courtney, Frederick A Brookfield, et al.
Pageof 54

Showing results (501-510 of 539) with videos related to

Sort By:
Pageof 54
Gynecologic Oncology|November 6, 2021
Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancerT J Orellana, H Kim, S Beriwal, et al.
Pediatric Diabetes|November 12, 2020
Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trialKate C Verbeeten, Maria Esther Perez Trejo, Ken Tang, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with AdV-IL2 (TG 1021) in unresectable digestive adenocarcinoma. Phase I-II study, first inclusionsF N Gilly, A C Sayag-Beaujard, J Bienvenu, et al.
Chemmedchem|April 23, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oximeRaffaella Amici, Chiara Bigogno, Roberto Boggio, et al.
BJU International|January 12, 2013
Discrediting microscopic pyuria and leucocyte esterase as diagnostic surrogates for infection in patients with lower urinary tract symptoms: results from a clinical and laboratory evaluationAnthony S Kupelian, Harry Horsley, Rajvinder Khasriya, et al.
The Journal of Clinical Investigation|December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsH Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Annals of Internal Medicine|December 1, 1979
Controlled trials of hemoperfusion for intoxicationO S Better, G Brunner, T M Chang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2022
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?S Jaishankar, P M Pifer, R Bhargava, et al.
Diabetologia|October 7, 2011
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a conceptJ Amar, M Serino, C Lange, et al.
Journal of Medicinal Chemistry|December 7, 2010
Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinaseMichael E Prime, Stephen M Courtney, Frederick A Brookfield, et al.
Pageof 54